Template:Crofab dosing: Difference between revisions

(Created page with "*Administer antivenom as soon as possible if the indications are met and antivenom is available.<ref>Dart RC et al. Efficacy of post envenomation administration of antivenin....")
 
Line 2: Line 2:
*Administration should slow swelling  and decrease pain
*Administration should slow swelling  and decrease pain
===Initial Administration===
===Initial Administration===
*The total volume but NOT the number of vials may be reduced in small children
*The dosing of CroFab is the same for adults and children
*Establish initial control of envenomation by giving 4-6 vials
*Establish initial control of envenomation by giving 4-6 vials
*Control achieved? (Cessation of progression of all components of envenomation, including labs checked 2 hours after infusion started)
*Control achieved? (Cessation of progression of all components of envenomation, including labs checked 2 hours after infusion started)
**'''If yes:'''the perform serial exams and consider maintenance therapy
**'''If yes: '''then perform serial exams and consider maintenance therapy
**'''If no:''' repeat infusion of 4-6 vials and then re-evaluate for control
**'''If no:''' repeat infusion of 4-6 vials and then re-evaluate for control
===Maintenance therapy===
===Maintenance therapy===
*''Maintance therapy may be indicated after initial dosing based on local protocols even if control is achieved.<ref>Crofab treatment agorithmn http://www.crofab.com/documents/CroFab-Treatment_Algorithm.pdf</ref>
*''Maintance therapy may be indicated after initial dosing based on local protocols even if control is achieved.<ref>Crofab treatment agorithmn http://www.crofab.com/documents/CroFab-Treatment_Algorithm.pdf</ref>

Revision as of 19:09, 1 January 2016

  • Administer antivenom as soon as possible if the indications are met and antivenom is available.[1]
  • Administration should slow swelling and decrease pain

Initial Administration

  • The dosing of CroFab is the same for adults and children
  • Establish initial control of envenomation by giving 4-6 vials
  • Control achieved? (Cessation of progression of all components of envenomation, including labs checked 2 hours after infusion started)
    • If yes: then perform serial exams and consider maintenance therapy
    • If no: repeat infusion of 4-6 vials and then re-evaluate for control

Maintenance therapy

  • Maintance therapy may be indicated after initial dosing based on local protocols even if control is achieved.[2]
    • Infuse 2-vial doses at 6, 12, and 18hr after initial control achieved

Envenomation control measurement

  • Must observe for progression of envenomation during and after antivenom infusion
  • Measure limb circumference at several site above and below bite
  • Mark advancing border of edema q30min
  • Repeat labs q4hr or after each course of antivenom (whichever is more frequent)

Antivenom Side Effects

  • Acute reactions occur in <10% pts
    • If occurs stop infusion and give antihistamines / epi if needed
  • Recurrent thrombocytopenia has been described up to 2 weeks after transfusion with FabAV and is likely a result of isolated renal clearance of FabAV and persistent presence of actual venom in serum.[3]
    • Only described in patients with history of thrombocytopenia during hospital course
    • Warrants close monitoring of platelets by primary physician or return visit after discharge
  1. Dart RC et al. Efficacy of post envenomation administration of antivenin. Toxicon. 1988;26:1218–1221.
  2. Crofab treatment agorithmn http://www.crofab.com/documents/CroFab-Treatment_Algorithm.pdf
  3. Ruha AM et al. Late hematologic toxicity following treatment of rattlesnake envenomation with crotalidae polyvalent immune Fab antivenom. Toxicon. 2011;57:53–59.